Secondary Logo

Journal Logo

Most Popular Articles

18F-FDG PET/CT in Hodgkin Lymphoma With Unsuspected COVID-19

Boulvard Chollet, Xavier L.E.; Romero Robles, Leonardo G.; Garrastachu, Puy; More

Clinical Nuclear Medicine. 45(8):652-653, August 2020.

SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer

Schmidkonz, Christian; Cordes, Michael; Beck, Michael; More

Clinical Nuclear Medicine. 43(4):225-231, April 2018.

Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?

Stathaki, Maria; Koukouraki, Sophia; Simos, Panagiotis; More

Clinical Nuclear Medicine. 45(8):588-593, August 2020.

89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2–Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

Ulaner, Gary A.; Hyman, David M.; Lyashchenko, Serge K.; More

Clinical Nuclear Medicine. 42(12):912-917, December 2017.

Minimal-Invasive Robot-Assisted Image-Guided Resection of Prostate-Specific Membrane Antigen–Positive Lymph Nodes in Recurrent Prostate Cancer

van Leeuwen, Fijs W. B.; van Oosterom, Matthias N.; Meershoek, Philippa; More

Clinical Nuclear Medicine. 44(7):580-581, July 2019.

Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-l-Tyrosine PET

Kertels, Olivia; Mihovilovic, Milena I.; Linsenmann, Thomas; More

Clinical Nuclear Medicine. 44(9):695-701, September 2019.

Initial Experience Using 99mTc-MIBI SPECT/CT for the Differentiation of Oncocytoma From Renal Cell Carcinoma

Rowe, Steven P.; Gorin, Michael A.; Gordetsky, Jennifer; More

Clinical Nuclear Medicine. 40(4):309-313, April 2015.

Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non–Small Cell Lung Cancer

Beer, Lucian; Hochmair, Maximilian; Haug, Alexander R.; More

Clinical Nuclear Medicine. 44(7):535-543, July 2019.

Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters

Lee, Hyunjong; Lee, Dong-eun; Park, Sohyun; More

Clinical Nuclear Medicine. 44(1):21-29, January 2019.

Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients

Berzaczy, Dominik; Giraudo, Chiara; Haug, Alexander R.; More

Clinical Nuclear Medicine. 42(9):669-674, September 2017.

Show: